Skip to main content

You have chosen not to allow videos from the 3rd party streaming service (YouTube), if you would like to see these videos, please change your Privacy policy and cookie settings.

Read our new annual Fertility Trends 2023 report here.

PGT-M conditions

The page below lists all PGT-M conditions currently authorised and awaiting consideration by the HFEA.

When publishing genetic conditions on the authorised list, we aim to be as consistent as possible with the OMIM database. However, many conditions may have several different names and we would recommend searching the list using the OMIM number for the condition as this is less likely to change throughout time.

If a condition does not appear on the list, it does not necessarily mean the condition has specifically not been authorised, it may mean that we have never before received an application from a UK centre to perform PGT-M for this condition and it has therefore never been considered by the HFEA.

Please note that we are always processing new applications to add genetic conditions to the list from UK centres licensed to perform PGT-M. This may mean that some authorised conditions may not be displayed. If you are unsure if a condition has been authorised or not, or would like any further information please contact the PGTM team at pgtm@hfea.gov.uk.

Click here for a downloadable list: approved condition list. Please note that the website page below is updated more regularly and is therefore more accurate than the downloadable list.

Condition name Status OMIM number Documents
Pulmonary Fibrosis and/or Bone Marrow Failure Syndrome, Telomere-Related, 1 (PFBMFT1) awaiting consideration 614742
Purine Nucleoside Phosphorylase Deficiency awaiting consideration 613179
Pycnodysostosis approved 265800
Pyogenic Arthritis, Pyoderma Gangrenosum and Acne Syndrome (PAPA) approved 604416
Pyruvate Dehydrogenase E1-Alpha Deficiency (PDHAD) approved 312170
Pyruvate Dehydrogenase E1-Beta Deficiency (PDHBD) approved 614111
Pyruvate Dehydrogenase E2 Deficiency (PDHDD) approved 245348
Pyruvate Dehydrogenase E3-Binding Protein Deficiency (PDHXD) approved 245349
Pyruvate Dehydrogenase Phosphatase Deficiency (PDHPD) approved 608782
Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia 1 (RUSAT1) approved 605432
Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia 2 (RUSAT2) approved 616738
Rapp-Hodgkin Syndrome (RHS) approved 129400
Recurrent Digynic Triploidy (due to publishing limitations, we can't provide a link to the relevant minutes - please contact HFEA.Licensing@HFEA.gov.uk if you would like to be sent a copy) approved
Recurrent infections with encephalopathy, hepatic dysfunction and cardiovascular malformations (FADD deficiency) approved 613759
Reducing Body Myopathy, X-Linked 1A, Severe, with Infantile or Early Childhood Onset (RBMX1A) approved 300717
Renal cell carcinoma, papillary, 1 (RCCP1) approved 605074
Renal Coloboma Syndrome approved 120330
Renal Cysts and Diabetes Syndrome (RCAD) approved 137920
Renal Hypodysplasia/Aplasia 3 (RHDA3) awaiting consideration 617805
Renal Tubular Dysgenesis (RTD) approved 267430